Yogiraj Ray

544 total citations
24 papers, 153 citations indexed

About

Yogiraj Ray is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yogiraj Ray has authored 24 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yogiraj Ray's work include COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Research on Leishmaniasis Studies (3 papers). Yogiraj Ray is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Research on Leishmaniasis Studies (3 papers). Yogiraj Ray collaborates with scholars based in India, United States and Vietnam. Yogiraj Ray's co-authors include Nitin Gupta, Naveet Wig, Manish Soneja, Ashutosh Biswas, Sayantan Banerjee, Ankit Mittal, Neeraj Nischal, Rudra Prosad Goswami, Rama Prosad Goswami and Md. Mustafizur Rahman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Yogiraj Ray

21 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yogiraj Ray India	7	96	65	38	28	17	24	153
Manish Soneja India	6	96 1.0×	89 1.4×	17 0.4×	22 0.8×	10 0.6×	30	142
Rachana Mehta India	7	59 0.6×	74 1.1×	48 1.3×	31 1.1×	5 0.3×	62	172
Mohammad Jokar Iran	8	45 0.5×	31 0.5×	23 0.6×	26 0.9×	24 1.4×	35	147
Savina Stoitsova Bulgaria	5	67 0.7×	27 0.4×	22 0.6×	24 0.9×	8 0.5×	9	146
Nicolás Aguayo Paraguay	6	79 0.8×	117 1.8×	70 1.8×	12 0.4×	4 0.2×	8	178
Mark G. Kortepeter United States	8	50 0.5×	81 1.2×	64 1.7×	38 1.4×	5 0.3×	11	170
Jamie A. Murkey United States	4	73 0.8×	50 0.8×	20 0.5×	30 1.1×	7 0.4×	6	145
Kelly Symmes United States	4	36 0.4×	80 1.2×	57 1.5×	21 0.8×	10 0.6×	6	130
Lauren E. Williamson United States	8	70 0.7×	135 2.1×	67 1.8×	36 1.3×	6 0.4×	18	193
Ana Belén Pérez Spain	10	94 1.0×	149 2.3×	12 0.3×	14 0.5×	9 0.5×	24	239

Countries citing papers authored by Yogiraj Ray

Since Specialization

Citations

This map shows the geographic impact of Yogiraj Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yogiraj Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yogiraj Ray more than expected).

Fields of papers citing papers by Yogiraj Ray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yogiraj Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yogiraj Ray. The network helps show where Yogiraj Ray may publish in the future.

Co-authorship network of co-authors of Yogiraj Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Yogiraj Ray. A scholar is included among the top collaborators of Yogiraj Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yogiraj Ray. Yogiraj Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yadav, Sunita, et al.. (2025). Temporal TCR dynamics and epitope diversity mark recovery in severe COVID-19 patients. Frontiers in Immunology. 16. 1582949–1582949.

Mehta, Priyanka, Partha Chattopadhyay, Ranit D’Rozario, et al.. (2023). Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study. Life Science Alliance. 7(1). e202302305–e202302305. 1 indexed citations

Bandopadhyay, Purbita, Yogiraj Ray, Jafar Sarif, et al.. (2023). Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19. Gut Pathogens. 15(1). 22–22. 8 indexed citations

D’Rozario, Ranit, Deblina Raychaudhuri, Purbita Bandopadhyay, et al.. (2023). Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19. Viruses. 15(2). 549–549. 6 indexed citations

Raychaudhuri, Deblina, Purbita Bandopadhyay, Ranit D’Rozario, et al.. (2022). Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19. SHILAP Revista de lepidopterología. 6(6). 511–524. 4 indexed citations

Das, Arijit, Yogiraj Ray, Bibhuti Saha, et al.. (2021). A prospective study on COVID‐19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre. ISBT Science Series. 16(4). 276–283. 3 indexed citations

Soneja, Manish, Nitin Gupta, Ankit Mittal, et al.. (2020). Nontuberculous mycobacteria: A report of eighteen cases from a tertiary care center in India. Lung India. 37(6). 495–495. 6 indexed citations

Banerjee, Sayantan, Nitin Gupta, Yogiraj Ray, et al.. (2020). Impact of trainee-driven Antimicrobial Stewardship Program in a high burden resource-limited setting.. PubMed. 28(3). 367–372. 5 indexed citations

Moitra, Saibal, et al.. (2020). Risk Benefit Analysis in Reference to use of LMWH in COVID-19.. Journal of the Association of Physicians of India. 68(9). 52–61. 1 indexed citations

10.

Fazal, Farhan, et al.. (2020). Collateral damage due to COVID-19. Tropical Doctor. 51(1). 126–127. 1 indexed citations

11.

Biswas, Sagnik, Arun Goel, Yogiraj Ray, et al.. (2019). Human trichinosis and febrile myositis. QJM. 112(6). 449–450.

12.

Banerjee, Sayantan, Nitin Gupta, Ankit Mittal, et al.. (2019). Nipah virus disease: A rare and intractable disease. Intractable & Rare Diseases Research. 8(1). 1–8. 69 indexed citations

13.

Mittal, Anshu, Yogiraj Ray, Manish Soneja, Mitali Chatterjee, & Pranav Kumar. (2019). Concurrent ocular and cutaneous leishmaniasis caused by Leishmania tropica. QJM. 113(4). 286–287. 1 indexed citations

14.

Ray, Yogiraj, et al.. (2018). SLE in a Male Patient Presented Initially as Rowell's Syndrome.. PubMed. 66(1). 98–9. 2 indexed citations

15.

Kundu, Santanu, et al.. (2017). Scleroderma-like Initial Presentation of Multiple Myeloma.. PubMed. 65(12). 93–95. 1 indexed citations

16.

Ray, Yogiraj, et al.. (2016). Nephritic syndrome and anasarca in a case of lymphatic filariasis: A rare association. Asian Pacific Journal of Tropical Disease. 6(6). 486–488. 2 indexed citations

17.

Ray, Yogiraj, et al.. (2014). Rare Association of Coeliac Disease with Aplastic Anaemia: Report of a Case from India. Indian Journal of Hematology and Blood Transfusion. 30(S1). 208–211. 7 indexed citations

18.

Goswami, Rama Prosad, et al.. (2014). Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting. International Journal of STD & AIDS. 26(12). 864–869. 10 indexed citations

19.

Goswami, Rama Prosad, et al.. (2013). Multiple intramuscular and hepatic echinococcosis.. PubMed. 61(12). 907–8.

20.

Goswami, Rudra Prosad, Sukhen Das, Yogiraj Ray, & Md. Mustafizur Rahman. (2012). Testing urine samples with rK39 strip as the simplest non-invasive field diagnosis for visceral leishmaniasis. Journal of Postgraduate Medicine. 58(3). 180–184. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact